101
|
Watanabe M, Ninomiya S, Kondo S, Matsumoto Y, Kamogawa K, Tomita H, Okamoto K, Okuda B, Mizuta I, Mizuno T. Clinical variety of two cases of hereditary sensory and autonomic neuropathy type 1E with cognitive disorders. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
102
|
Kitani-Morii F, Imamura K, Kondo T, Ohara R, Yamamoto T, Sekiguchi K, Toguchida J, Mizuno T, Nakagawa M, Inoue H. iPSC model for demyelinating Charcot-Marie-Tooth disease. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
103
|
Kondo M, Ohmichi T, Tsuji Y, Masanori M, Mizuno T. Constructive disturbance and abnormal regional cerebral blood flow distribution in amyotrophic lateral sclerosis with dementia. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
104
|
Abstract
The teleost dorsoventral axis cannot be distinguished morphologically before gastrulation. In order to examine whether the yolk cell affects axis determination, we bisect early cleavage embryos of the goldfish, Carassius auratus. When the vegetal yolk hemisphere is removed by bisection along the equatorial plane at the 2-cell stage, the embryos develop abnormally and exhibit a symmetrical morphology. No dorsal structures, such as notochord, somites and neural tube, differentiate and no embryonic shield is formed during gastrulation. In addition, no goosecoid mRNA is expressed before gastrulation. The frequency of abnormality decreases as the age at which the vegetal yolk hemisphere is removed increases. Most embryos removed at the 32-cell stage develop normally. Their morphological phenotype is similar to that of a Xenopus ventralized embryo generated by ultraviolet irradiation on the vegetal hemisphere soon after fertilization. We also observed that, when the embryos were bisected along the first cleavage plane at the 2-cell stage, the proportion of pairs of embryos of which one embryo developed normally was 44.8%. These results indicate that the vegetal yolk hemisphere of the early cleavage embryo of the goldfish contains axis determination factor(s), which are necessary for generation of dorsal structures. Furthermore, it is suggested that these determinant(s) are distributed asymmetrically within the vegetal yolk hemisphere.
Collapse
Affiliation(s)
- T Mizuno
- Department of Molecular Biology, School of Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-01 Japan, , , , , , JP
| | - Etsuro Yamaha
- Nanae Fish Culture Experimental Station, Faculty of Fisheries, Hokkaido University, 498 Sakura, Nanae, Kameda-gun, Hokkaido, 041-11 Japan, , , , , , JP
| | - Fumio Yamazaki
- Laboratory of Embryology and Genetics, Faculty of Fisheries, Hokkaido University, Minato-cho, Hakodate, Hokkaido, 041 Japan, , , , , , JP
| |
Collapse
|
105
|
Kawano K, Mizuno T. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis. Vet Dermatol 2017; 28:583-e141. [DOI: 10.1111/vde.12470] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/11/2017] [Indexed: 01/19/2023]
Affiliation(s)
- Kouji Kawano
- Primo Animal Hospital Tokyo Animal Allergy Medical Center (AAMC); 1-28-7 Shakujiimachi Nerima-Ku Tokyo 177-0041 Japan
- Laboratory of Molecular Diagnostics and Therapeutics; The United Graduate School of Veterinary Science; Yamaguchi University; 1677-1 Yoshida Yamaguchi Yamaguchi 753-8515 Japan
| | - Takuya Mizuno
- Laboratory of Molecular Diagnostics and Therapeutics; The United Graduate School of Veterinary Science; Yamaguchi University; 1677-1 Yoshida Yamaguchi Yamaguchi 753-8515 Japan
- Biomedical Science Center for Translational Research; The United Graduate School of Veterinary Science; Yamaguchi University; 1677-1 Yoshida Yamaguchi Yamaguchi 753-8515 Japan
| |
Collapse
|
106
|
Mukai K, Mizuno T, Nakano Y, Niwa T, Watanabe A, Wakabayashi H, Ando H, Takashima H, Waseda K, Amano T. P1434The usefulness of tricuspid annular plane systolic excursion, the index of right ventricular performance, to detect low stroke index. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
107
|
Sakai O, Sakurai M, Sakai H, Kubo M, Hiraoka H, Baba K, Okuda M, Mizuno T. Molecular cloning of canine Wilms' tumor 1 for immunohistochemical analysis in canine tissues. J Vet Med Sci 2017; 79:1272-1277. [PMID: 28603218 PMCID: PMC5559376 DOI: 10.1292/jvms.17-0229] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Wilms’ tumor 1 (WT1) expression has been investigated in various human cancers as a target molecule for cancer immunotherapy. However, few studies have focused on WT1 expression in dogs. Firstly, cDNA of canine WT1 (cWT1) was
molecularly cloned from normal canine kidney. The cross-reactivity of the anti-human WT1 monoclonal antibody (6F-H2) with cWT1 was confirmed via Western blotting using cells overexpressing cWT1. Immunohistochemical staining
revealed that cWT1 expression was detected in all canine lymphoma tissues and in some normal canine tissues, including the kidney and lymph node. cWT1 is a potential immunotherapy target against canine cancers.
Collapse
Affiliation(s)
- Osamu Sakai
- Laboratory of Molecular Diagnostics and Therapeutics, The United Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | - Masashi Sakurai
- Laboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | - Hiroki Sakai
- Laboratory of Veterinary Pathology, Pathogenetic Veterinary Medicine, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193, Japan
| | - Masahito Kubo
- Laboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | - Hiroko Hiraoka
- Laboratory of Molecular Diagnostics and Therapeutics, The United Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | - Kenji Baba
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | - Masaru Okuda
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | - Takuya Mizuno
- Laboratory of Molecular Diagnostics and Therapeutics, The United Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| |
Collapse
|
108
|
Hara K, Iio A, Asahina R, Takahashi M, Mori T, Nishida H, Kamishina H, Sakai H, Kitoh K, Mizuno T, Tsujimoto H, Maeda S. Characterization of a novel canine T-cell line established from a dog with cutaneous T-cell lymphoma. J Dermatol Sci 2017; 88:254-256. [PMID: 28668559 DOI: 10.1016/j.jdermsci.2017.06.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2017] [Revised: 05/26/2017] [Accepted: 06/01/2017] [Indexed: 11/25/2022]
Affiliation(s)
- Kyohei Hara
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Aki Iio
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Ryota Asahina
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Maiko Takahashi
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Takashi Mori
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Hidetaka Nishida
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Hiroaki Kamishina
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Hiroki Sakai
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Katsuya Kitoh
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan
| | - Takuya Mizuno
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan
| | - Hajime Tsujimoto
- Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
| | - Sadatoshi Maeda
- Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
| |
Collapse
|
109
|
Nemoto Y, Haraguchi T, Shimokawa Miyama T, Kobayashi K, Hama K, Kurogouchi Y, Fujiki N, Baba K, Okuda M, Mizuno T. Pancreatic Abscess in a cat due to Staphylococcus aureus infection. J Vet Med Sci 2017; 79:1146-1150. [PMID: 28529270 PMCID: PMC5559355 DOI: 10.1292/jvms.17-0026] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
A 16-year-old spayed female American Shorthair cat was presented with lethargy, anorexia, and wamble. Physical and blood examination did not reveal any remarkable findings. Abdominal ultrasonography identified the presence of a localized anechoic structure with a thick wall in contact with the small intestine and adjacent to the liver. Ultrasound-guided fine-needle aspiration of the structure revealed fluid containing numerous cocci and neutrophils. Two days after antibiotic treatment, exploratory laparotomy was performed and the content of the structure was removed before multiple lavages. The pathological and bacteriological examination results supported a confirmatory diagnosis of pancreatic abscess due to Staphylococcus aureus infection, making this the first such report in a cat. The cat remained healthy thereafter with no disease recurrence.
Collapse
Affiliation(s)
- Yuki Nemoto
- Laboratory of Molecular Diagnostics and Therapeutics, Department of Veterinary Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Tomoya Haraguchi
- Laboratory of Veterinary Surgery, Department of Veterinary Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Takako Shimokawa Miyama
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Kosuke Kobayashi
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Kaori Hama
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Yosuke Kurogouchi
- Laboratory of Molecular Diagnostics and Therapeutics, Department of Veterinary Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Noriyuki Fujiki
- Laboratory of Molecular Diagnostics and Therapeutics, Department of Veterinary Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Kenji Baba
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Masaru Okuda
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | - Takuya Mizuno
- Laboratory of Molecular Diagnostics and Therapeutics, Department of Veterinary Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| |
Collapse
|
110
|
Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Br J Surg 2017; 105:829-838. [PMID: 28488733 DOI: 10.1002/bjs.10556] [Citation(s) in RCA: 78] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2016] [Revised: 02/26/2017] [Accepted: 03/03/2017] [Indexed: 12/13/2022]
Abstract
BACKGROUND Bismuth type IV perihilar cholangiocarcinoma has traditionally been categorized as unresectable disease. The aim of this study was to review experience with a resection-based strategy in patients who have type IV perihilar cholangiocarcinoma. METHODS Medical records of consecutive patients with a diagnosis of type IV perihilar cholangiocarcinoma between 2006 and 2015 were reviewed retrospectively. Primary outcomes assessed were surgical results and long-term survival. RESULTS Of the 332 patients with type IV tumour, 216 (65·1 per cent) underwent resection. Left hepatic trisectionectomy was the most common procedure (112 patients). Combined vascular resection was performed in 131 patients. Median duration of operation was 607 (range 356-1045) min, and blood loss was 1357 (209-10 349) ml. Complications of Clavien-Dindo grade III or more developed in 90 patients (41·7 per cent) and four (1·9 per cent) died from complications within 90 days. Survival rates were better for the 216 patients whose tumours were resected than for the 116 patients with unresected tumours (32·8 versus 1·5 per cent at 5 years; P < 0·001). Patients with pN0 M0 disease after resection had a favourable 5-year survival rate of 53 per cent. Percutaneous transhepatic biliary drainage, blood transfusion, lymph node metastasis and distant metastasis were identified as independent negative prognostic factors for survival. CONCLUSION Although resection for type IV tumour is technically demanding with high morbidity, it can be performed with low mortality and offers better survival probability in selected patients.
Collapse
Affiliation(s)
- T Ebata
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan
| | - T Mizuno
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan
| | - Y Yokoyama
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan
| | - T Igami
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan
| | - G Sugawara
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan
| | - M Nagino
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan
| |
Collapse
|
111
|
Sakao Y, Kuroda H, Mizuno T, Sakakura N, Yatabe Y. The solid component evaluated on computed tomography can predict the invasiveness and lymph node metastasis in lung adenocarcinoma as well as pathological invasive size. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx086.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
112
|
Mizuno T, Tsukiya T, Takewa Y, Tatsumi E. Comparisons in Clotting Parameters Between Species for Preclinical Animal Studies. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.1541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
113
|
Noguchi S, Shibutani S, Fukushima K, Mori T, Igase M, Mizuno T. Bosutinib, an SRC inhibitor, induces caspase-independent cell death associated with permeabilization of lysosomal membranes in melanoma cells. Vet Comp Oncol 2017; 16:69-76. [DOI: 10.1111/vco.12312] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2017] [Revised: 02/15/2017] [Accepted: 03/07/2017] [Indexed: 12/14/2022]
Affiliation(s)
- S. Noguchi
- Laboratory of Veterinary Radiology, Graduate School of Life and Environmental Sciences; Osaka Prefecture University; Osaka Japan
- Biomedical Science Center for Translational Research, The United Graduate School of Veterinary Science; Yamaguchi University; Yamaguchi Japan
| | - S. Shibutani
- Laboratory of Veterinary Hygiene, Joint Faculty of Veterinary Medicine; Yamaguchi University; Yamaguchi Japan
| | - K. Fukushima
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine; Yamaguchi University; Yamaguchi Japan
| | - T. Mori
- Laboratory of Veterinary Clinical Oncology, Faculty of Applied Biological Sciences; Gifu University; Gifu Japan
| | - M. Igase
- The United Graduate School of Veterinary Science; Yamaguchi University; Yamaguchi Japan
| | - T. Mizuno
- Biomedical Science Center for Translational Research, The United Graduate School of Veterinary Science; Yamaguchi University; Yamaguchi Japan
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine; Yamaguchi University; Yamaguchi Japan
| |
Collapse
|
114
|
Hata H, Natori T, Mizuno T, Kanazawa I, Eldesouky I, Hayashi M, Miyata M, Fukunaga H, Ohji S, Hosoyama A, Aono E, Yamazoe A, Tsuchikane K, Fujita N, Ezaki T. Phylogenetics of family Enterobacteriaceae and proposal to reclassify Escherichia hermannii and Salmonella subterranea as Atlantibacter hermannii and Atlantibacter subterranea gen. nov., comb. nov. Microbiol Immunol 2017; 60:303-11. [PMID: 26970508 DOI: 10.1111/1348-0421.12374] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2015] [Revised: 02/25/2016] [Accepted: 03/07/2016] [Indexed: 11/27/2022]
Abstract
Multilocus sequence analysis based on hypervariable housekeeping proteins was utilized to differentiate closely related species in the family Enterobacteriaceae. Of 150 housekeeping proteins, the top 10 hypervariable proteins were selected and concatenated to obtain distance data. Distances between concatenated proteins within the family were 0.9-41.2%, whereas the 16S rRNA and atpD-gyrB-infB-rpoB concatenated sequence (4MLSA) distances were 0.8-6.0% and 0.9-22.1%, respectively. These data indicate that phylogenetic analysis by concatenation of hypervariable proteins is a powerful tool for discriminating species in the family Enterobacteriaceae. To confirm the discriminatory power of the 10 chosen concatenated hypervariable proteins (C10HKP), phylogenetic trees based on C10HKP, 4MLSA, and the 16S rRNA gene were constructed. Comparison of average bootstrap values among C10HKP, 4MLSA and 16S rRNA genes indicated that the C10HKP tree was the most reliable. Location via the C10HKP tree was consistent with existing assignments for almost all species in the family Enterobacteriaceae. However, the C10HKP tree suggested that several species (including Enterobacter massiliensis, Escherichia vulneris, Escherichia hermannii, and Salmonella subterranea) should be reassigned to different clusters than those defined in previous analyses. Furthermore, E. hermannii and S. subterranea appeared to fall onto a branch independent from those occupied by the other Enterobacteriaceae. Therefore, we propose Atlantibacter gen. nov., such that E. hermannii and S. subterranea would be transferred to genus Atlantibacter as Atlantibacter hermannii, comb. nov. and Atlantibacter subterranea. comb. nov., respectively.
Collapse
Affiliation(s)
- Hiroyuki Hata
- Department of Microbiology, Gifu University Graduate School of Medicine
| | - Tatsuya Natori
- Department of Microbiology, Gifu University Graduate School of Medicine
| | - Takuya Mizuno
- Department of Microbiology, Gifu University Graduate School of Medicine
| | - Izumi Kanazawa
- Department of Microbiology, Gifu University Graduate School of Medicine
| | - Ibrahim Eldesouky
- Department of Bacteriology, Mycology and Immunology, Faculty of Veterinary Medicine, Kafrelsheikh University, 33516, Egypt
| | - Masahiro Hayashi
- Division of Anaerobe Research, Life Science Research Center, Gifu University, 1-1 Yanagido, Gifu 501-1194
| | - Machiko Miyata
- Department of Microbiology, Gifu University Graduate School of Medicine
| | - Hajime Fukunaga
- Department of Microbiology, Gifu University Graduate School of Medicine
| | - Shoko Ohji
- Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8, Kazusakamatari, Kisarazu-shi, Chiba 292-0818, Japan
| | - Akira Hosoyama
- Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8, Kazusakamatari, Kisarazu-shi, Chiba 292-0818, Japan
| | - Eiji Aono
- Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8, Kazusakamatari, Kisarazu-shi, Chiba 292-0818, Japan
| | - Atsushi Yamazoe
- Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8, Kazusakamatari, Kisarazu-shi, Chiba 292-0818, Japan
| | - Keiko Tsuchikane
- Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8, Kazusakamatari, Kisarazu-shi, Chiba 292-0818, Japan
| | - Nobuyuki Fujita
- Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8, Kazusakamatari, Kisarazu-shi, Chiba 292-0818, Japan
| | - Takayuki Ezaki
- Department of Microbiology, Gifu University Graduate School of Medicine
| |
Collapse
|
115
|
Abdollahi S, Ackermann M, Ajello M, Albert A, Atwood WB, Baldini L, Barbiellini G, Bellazzini R, Bissaldi E, Bloom ED, Bonino R, Bottacini E, Brandt TJ, Bruel P, Buson S, Caragiulo M, Cavazzuti E, Chekhtman A, Ciprini S, Costanza F, Cuoco A, Cutini S, D'Ammando F, de Palma F, Desiante R, Digel SW, Di Lalla N, Di Mauro M, Di Venere L, Donaggio B, Drell PS, Favuzzi C, Focke WB, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Giroletti M, Green D, Guiriec S, Harding AK, Jogler T, Jóhannesson G, Kamae T, Kuss M, Larsson S, Latronico L, Li J, Longo F, Loparco F, Lubrano P, Magill JD, Malyshev D, Manfreda A, Mazziotta MN, Meehan M, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Negro M, Nuss E, Ohsugi T, Omodei N, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Principe G, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Sgrò C, Simone D, Siskind EJ, Spada F, Spandre G, Spinelli P, Strong AW, Tajima H, Thayer JB, Torres DF, Troja E, Vandenbroucke J, Zaharijas G, Zimmer S. Search for Cosmic-Ray Electron and Positron Anisotropies with Seven Years of Fermi Large Area Telescope Data. Phys Rev Lett 2017; 118:091103. [PMID: 28306280 DOI: 10.1103/physrevlett.118.091103] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2016] [Indexed: 06/06/2023]
Abstract
The Large Area Telescope on board the Fermi Gamma-ray Space Telescope has collected the largest ever sample of high-energy cosmic-ray electron and positron events since the beginning of its operation. Potential anisotropies in the arrival directions of cosmic-ray electrons or positrons could be a signature of the presence of nearby sources. We use almost seven years of data with energies above 42 GeV processed with the Pass 8 reconstruction. The present data sample can probe dipole anisotropies down to a level of 10^{-3}. We take into account systematic effects that could mimic true anisotropies at this level. We present a detailed study of the event selection optimization of the cosmic-ray electrons and positrons to be used for anisotropy searches. Since no significant anisotropies have been detected on any angular scale, we present upper limits on the dipole anisotropy. The present constraints are among the strongest to date probing the presence of nearby young and middle-aged sources.
Collapse
Affiliation(s)
- S Abdollahi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M Ackermann
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M Ajello
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, South Carolina 29634-0978, USA
| | - A Albert
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - W B Atwood
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, California 95064, USA
| | - L Baldini
- Dipartimento di Fisica "Enrico Fermi" dell'Università di Pisa, I-56126 Pisa, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - R Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E Bissaldi
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E D Bloom
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - R Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica, Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Bottacini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - T J Brandt
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - P Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, F-91128 Palaiseau, France
| | - S Buson
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M Caragiulo
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E Cavazzuti
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - A Chekhtman
- College of Science, George Mason University, Fairfax, Virginia 22030, USA resident at Naval Research Laboratory, Washington, DC 20375, USA
| | - S Ciprini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - F Costanza
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - A Cuoco
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Institute for Theoretical Particle Physics and Cosmology, (TTK), RWTH Aachen University, D-52056 Aachen, Germany
| | - S Cutini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - F D'Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - F de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - S W Digel
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - N Di Lalla
- Dipartimento di Fisica "Enrico Fermi" dell'Università di Pisa, I-56126 Pisa, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M Di Mauro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - L Di Venere
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - B Donaggio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - P S Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - C Favuzzi
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - W B Focke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - Y Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P Fusco
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - F Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D Gasparrini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - N Giglietto
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - F Giordano
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - M Giroletti
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
| | - D Green
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - S Guiriec
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - A K Harding
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - T Jogler
- Friedrich-Alexander-Universität, Erlangen-Nürnberg, Schlossplatz 4, 91054 Erlangen, Germany
| | - G Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - T Kamae
- Department of Physics, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - M Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S Larsson
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - F Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F Loparco
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - P Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - J D Magill
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - D Malyshev
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - A Manfreda
- Dipartimento di Fisica "Enrico Fermi" dell'Università di Pisa, I-56126 Pisa, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M N Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - M Meehan
- Department of Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - P F Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - T Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A A Moiseev
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
- Center for Research and Exploration in Space Science and Technology (CRESST) and NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M E Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata", I-00133 Roma, Italy
| | - M Negro
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica, Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | - T Ohsugi
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - N Omodei
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - D Paneque
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J S Perkins
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M Pesce-Rollins
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - F Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | - G Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Principe
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - S Rainò
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - M Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - A Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - C Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - D Simone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E J Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P Spinelli
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - A W Strong
- Max-Planck Institut für extraterrestrische Physik, D-85748 Garching, Germany
| | - H Tajima
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya 464-8601, Japan
| | - J B Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - D F Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), E-08010 Barcelona, Spain
| | - E Troja
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - J Vandenbroucke
- Department of Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - G Zaharijas
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, and Università di Trieste, I-34127 Trieste, Italy
- Laboratory for Astroparticle Physics, University of Nova Gorica, Vipavska 13, SI-5000 Nova Gorica, Slovenia
| | - S Zimmer
- Département de Physique Nucléaire et Corpuscolaire (DPNC), University of Geneva, CH-1211 Genéve 4, Switzerland
| |
Collapse
|
116
|
Ohara R, Imamura K, Morii F, Egawa N, Tsukita K, Enami T, Shibukawa R, Mizuno T, Nakagawa M, Inoue H. Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology. Clin Pharmacol Ther 2017; 101:754-762. [PMID: 27859025 DOI: 10.1002/cpt.562] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2016] [Revised: 10/11/2016] [Accepted: 11/06/2016] [Indexed: 12/14/2022]
Abstract
Drugs under development can cause unpredicted toxicity in humans due to differential drug responsiveness between humans and other disease models, resulting in clinical trial failures. Human induced pluripotent stem cells (iPSCs) are expected to represent a useful tool for toxicity testing. However, among many assays, appropriate cellular assays for predicting neurotoxicity in an iPSC-based model are still uncertain. Here we generated neurons from iPSCs of Charcot-Marie-Tooth disease (CMT) patients. Some CMT patients are sensitive to anticancer drugs and present with an adverse reaction of neuropathy. We analyzed cellular phenotypes and found that mitochondria in neurites of CMT neurons were morphologically shorter and showed slower mobility compared to control. A neurosphere assay showed that treatment with drugs known to cause neuropathy caused mitochondrial aggregations in neurites with adenosine triphosphate shortage in both CMT and control neurons, although more severely in CMT. These findings suggest that the genetically susceptible model could provide a useful tool to predict drug-induced neurotoxicity.
Collapse
Affiliation(s)
- R Ohara
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan.,Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - K Imamura
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan
| | - F Morii
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan.,Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - N Egawa
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan
| | - K Tsukita
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan
| | - T Enami
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan
| | - R Shibukawa
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan
| | - T Mizuno
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - M Nakagawa
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan.,North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - H Inoue
- Center for iPS Cells for Research and Application (CiRA), Kyoto University, Kyoto, Japan
| |
Collapse
|
117
|
Dejima H, Kuroda H, Seto K, Sakata S, Mizuno T, Sakakura N, Sakao Y. 421P Diagnosis of right upper lobar lymph node metastasis by modified TLG. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw591.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
118
|
Noguchi S, Kumazaki M, Mori T, Baba K, Okuda M, Mizuno T, Akao Y. Cover Image, Volume 14, Issue 4. Vet Comp Oncol 2016. [DOI: 10.1111/vco.12283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- S. Noguchi
- Laboratory of Molecular Diagnostic and Therapeutics; Joint faculty of Veterinary Medicine, Yamaguchi University; Yamaguchi Japan
| | - M. Kumazaki
- The United Graduate School of Drug Discovery and Medical Information Sciences; Gifu University; Gifu Japan
| | - T. Mori
- Laboratory of Veterinary Clinical Oncology; Faculty of Applied Biological Sciences, Gifu University; Gifu Japan
| | - K. Baba
- Laboratory of Veterinary Internal Medicine; Joint Faculty of Veterinary Medicine, Yamagushi University; Yamaguchi Japan
| | - M. Okuda
- Laboratory of Veterinary Internal Medicine; Joint Faculty of Veterinary Medicine, Yamagushi University; Yamaguchi Japan
| | - T. Mizuno
- Laboratory of Molecular Diagnostic and Therapeutics; Joint faculty of Veterinary Medicine, Yamaguchi University; Yamaguchi Japan
| | - Y. Akao
- The United Graduate School of Drug Discovery and Medical Information Sciences; Gifu University; Gifu Japan
| |
Collapse
|
119
|
Kobayashi K, Shimokawa Miyama T, Itamoto K, Noguchi S, Baba K, Mizuno T, Okuda M. Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog. J Vet Med Sci 2016; 78:1611-1614. [PMID: 27320967 PMCID: PMC5095632 DOI: 10.1292/jvms.16-0019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
A 2-year-old female beagle was referred to our hospital for evaluation of anemia. Laboratory tests, including bone marrow cytology, revealed non-regenerative immune-mediated anemia (NRIMA). Although initial immunosuppressive multi-drug therapy was not effective, additional administration of danazol was successful in treating the anemia. However, hepatocellular carcinoma (HCC) developed about 20 months after the administration of danazol. In humans, several cases of development of HCC after the administration of danazol have been reported. The present report describes a case of HCC development in a dog after chronic administration of danazol in addition to other immunosuppressive drugs.
Collapse
Affiliation(s)
- Kosuke Kobayashi
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1, Yoshida, Yamaguchi 753-8511, Japan
| | | | | | | | | | | | | |
Collapse
|
120
|
Affiliation(s)
- T Mizuno
- Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan.,School of Health and Sport Sciences, Chukyo University, Toyota, Japan
| | - Y Umemura
- School of Health and Sport Sciences, Chukyo University, Toyota, Japan
| |
Collapse
|
121
|
Konno T, Yoshida K, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Nishizawa M, Onodera O, Wszolek ZK, Ikeuchi T. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. Eur J Neurol 2016; 24:37-45. [PMID: 27680516 PMCID: PMC5215554 DOI: 10.1111/ene.13125] [Citation(s) in RCA: 87] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2016] [Accepted: 08/09/2016] [Indexed: 01/13/2023]
Abstract
Background and purpose The clinical characteristics of colony stimulating factor 1 receptor (CSF1R) related adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) have been only partially elucidated. Methods Clinical data from CSF1R mutation carriers who had been seen at our institutions or reported elsewhere were collected and analysed using a specific investigation sheet to standardize the data. Results In all, 122 cases from 90 families with CSF1R mutations were identified. The mean age of onset was 43 years (range 18–78 years), the mean age at death was 53 years (range 23–84 years) and the mean disease duration was 6.8 years (range 1–29 years). Women had a significantly younger age of onset than men (40 vs. 47 years, P = 0.0006, 95% confidence interval 3.158–11.177). There was an age‐dependent penetrance that was significantly different between the sexes (P = 0.0013). Motor dysfunctions were the most frequent initial symptom in women whose diseases began in their 20s. Thinning of the corpus callosum, abnormal signalling in pyramidal tracts, diffusion‐restricted lesions and calcifications in the white matter were characteristic imaging findings of ALSP. The calcifications were more frequently reported in our case series than in the literature (54% vs. 3%). Seventy‐nine per cent of the mutations were located in the distal part of the tyrosine kinase domain of CSF1R (102 cases). There were no apparent phenotype−genotype correlations. Conclusions The characteristics of ALSP were clarified. The phenotype of ALSP caused by CSF1R mutations is affected by sex.
Collapse
Affiliation(s)
- T Konno
- Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.,Department of Neurology, Niigata University, Niigata, Japan
| | - K Yoshida
- Department of Brain Disease Research, Shinshu University School of Medicine, Matsumoto, Japan
| | - T Mizuno
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - T Kawarai
- Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
| | - M Tada
- Department of Neurology, Niigata University, Niigata, Japan
| | - H Nozaki
- Department of Medical Technology, School of Health Sciences Faculty of Medicine, Niigata University, Niigata, Japan
| | - S-I Ikeda
- Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan
| | - M Nishizawa
- Department of Neurology, Niigata University, Niigata, Japan
| | - O Onodera
- Department of Molecular Neuroscience, Niigata University, Niigata, Japan
| | - Z K Wszolek
- Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
| | - T Ikeuchi
- Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan
| |
Collapse
|
122
|
Abstract
The purpose of this study was to identify changes in ankle range of motion and passive mechanical properties of the muscle-tendon unit after dynamic stretching. 12 healthy subjects participated in this study. Displacement of the muscle-tendon junction was measured using ultrasonography while the ankle was passively dorsiflexed at 1°/sec to its maximal dorsiflexion angle. Passive torque was also measured using an isokinetic dynamometer. Measurements were conducted pre-intervention, immediately after the intervention and 5, 10, 15 and 30 min post-intervention. The dynamic stretching consisted of four 30-s periods of ankle dorsiflexion and plantarflexion. Ankle range of motion was significantly increased immediately (from 18.3±1.8° to 21.4±1.7°) and 10 min (20.9±1.9°) after dynamic stretching, but this change disappeared within 15 min. However, stiffness of the muscle-tendon unit and displacement of the muscle-tendon junction at the submaximal dorsiflexion angle did not differ between the experimental conditions. These results demonstrate that dynamic stretching by contracting an antagonist muscle group increases ankle range of motion temporarily without changing the passive mechanical properties of the muscle-tendon unit. The increased range of motion of the ankle after dynamic stretching might be caused by enhanced stretch tolerance.
Collapse
Affiliation(s)
- T Mizuno
- Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan
| | - Y Umemura
- Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan
| |
Collapse
|
123
|
Roode SC, Rotroff D, Richards KL, Moore P, Motsinger-Reif A, Okamura Y, Mizuno T, Tsujimoto H, Suter SE, Breen M. Comprehensive genomic characterization of five canine lymphoid tumor cell lines. BMC Vet Res 2016; 12:207. [PMID: 27639374 PMCID: PMC5027081 DOI: 10.1186/s12917-016-0836-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Accepted: 09/08/2016] [Indexed: 01/13/2023] Open
Abstract
BACKGROUND Leukemia/lymphoma cell lines have been critical in the investigation of the pathogenesis and therapy of hematological malignancies. While human LL cell lines have generally been found to recapitulate the primary tumors from which they were derived, appropriate characterization including cytogenetic and transcriptional assessment is crucial for assessing their clinical predictive value. RESULTS In the following study, five canine LL cell lines, CLBL-1, Ema, TL-1 (Nody-1), UL-1, and 3132, were characterized using extensive immunophenotyping, karyotypic analysis, oligonucleotide array comparative genomic hybridization (oaCGH), and gene expression profiling. Genome-wide DNA copy number data from the cell lines were also directly compared with 299 primary canine round cell tumors to determine whether the cell lines represent primary tumors, and, if so, what subtype each most closely resembled. CONCLUSIONS Based on integrated analyses, CLBL-1 was classified as B-cell lymphoma, Ema and TL-1 as T-cell lymphoma, and UL-1 as T-cell acute lymphoblastic leukemia. 3132, originally classified as a B-cell lymphoma, was reclassified as a histiocytic sarcoma based on characteristic cytogenomic properties. In combination, these data begin to elucidate the clinical predictive value of these cell lines which will enhance the appropriate selection of in vitro models for future studies of canine hematological malignancies.
Collapse
Affiliation(s)
- Sarah C Roode
- Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, CVM Research Building - Room 348, 1060 William Moore Drive, Raleigh, 27607, NC, USA
| | - Daniel Rotroff
- Bioinformatics Research Center, Department of Statistics, North Carolina State University, Raleigh, NC, USA
| | - Kristy L Richards
- Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
- Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA
- Cancer Genetics Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
- KLR current address: Department of Biomedical Sciences, Cornell University, Ithaca, NY, USA
| | - Peter Moore
- Department of Pathology, Microbiology, and Immunology, College of Veterinary Medicine, University of California, Davis, CA, USA
| | - Alison Motsinger-Reif
- Bioinformatics Research Center, Department of Statistics, North Carolina State University, Raleigh, NC, USA
- Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA
| | - Yasuhiko Okamura
- Veterinary Teaching Hospital, Faculty of Agriculture, Iwate University, Morioka, Japan
| | - Takuya Mizuno
- Laboratory of Veterinary Internal Medicine, Faculty of Agriculture, Yamaguchi University, Yamaguchi, Japan
| | - Hajime Tsujimoto
- Graduate School of Agricultural and Life Sciences, University of Tokyo, Bunkyo, Japan
| | - Steven E Suter
- Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA.
- Cancer Genetics Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, CVM Research Building - Room 308, 1051 William Moore Drive, Raleigh, NC, 27607, USA.
| | - Matthew Breen
- Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, CVM Research Building - Room 348, 1060 William Moore Drive, Raleigh, 27607, NC, USA.
- Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA.
- Cancer Genetics Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
| |
Collapse
|
124
|
Ashida R, Okamura Y, Nakao K, Mizuno T, Aoki S, Kiuchi R, Sugiura T, Ito T, Yamamoto Y, Mochizuki T, Uesaka K. MON-P241: The Impact of Preoperative Enteral Nutrition Enriched Administration with Eicosapentaenoic Acid (EPA) on Postoperative Hypercytokinemia after Pancreatoduodenectomy: Results of a Double-Blinded Randomized Controlled Trial. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30875-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
125
|
Emoto C, Fukuda T, Mizuno T, Schniedewind B, Christians U, Adams DM, Vinks AA. Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants. CPT Pharmacometrics Syst Pharmacol 2016; 5:411-7. [PMID: 27501453 PMCID: PMC4999604 DOI: 10.1002/psp4.12096] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/31/2016] [Revised: 06/07/2016] [Accepted: 06/21/2016] [Indexed: 01/25/2023]
Abstract
Sirolimus is increasingly being used in neonates and infants, but the mechanistic basis of age‐dependent changes in sirolimus disposition has not been fully addressed yet. In order to characterize the age‐dependent changes, serial sirolimus clearance (CL) estimates in individual young pediatric patients were collected and analyzed by population modeling analysis. In addition, sirolimus metabolite formation was also investigated to further substantiate the corresponding age‐dependent change in CYP3A activity. The increasing pattern over time of allometrically size‐normalized sirolimus CL estimates vs. age was well described by a sigmoidal Emax model. This age‐dependent increase was also observed within each individual patient over a 4‐year study period. CYP3A‐dependent sirolimus metabolite formation changed in a similar fashion. This study clearly demonstrates the rapid increase of sirolimus CL over time in neonates and infants, indicating the developmental change. This developmental pattern can be explained by a parallel increase in CYP3A metabolic activity.
Collapse
Affiliation(s)
- C Emoto
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.,Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - T Fukuda
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.,Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - T Mizuno
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - B Schniedewind
- iC42 Integrated Solutions in Clinical Research and Development, University of Colorado, Anschutz Medical Center, Aurora, Colorado, USA
| | - Uwe Christians
- iC42 Integrated Solutions in Clinical Research and Development, University of Colorado, Anschutz Medical Center, Aurora, Colorado, USA
| | - D M Adams
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.,Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - A A Vinks
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.,Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| |
Collapse
|
126
|
Hayashi N, Takada Y, Mizuno T, Nakae H, Murai T. SU-F-T-255: Accuracy and Precision of Dynamic Tracking Irradiation with VERO-4DRT System. Med Phys 2016. [DOI: 10.1118/1.4956395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
127
|
Kawano K, Shimakura H, Nagata N, Masashi Y, Suto A, Suto Y, Uto S, Ueno H, Hasegawa T, Ushigusa T, Nagai T, Arawatari Y, Miyaji K, Ohmori K, Mizuno T. Prevalence of food-responsive enteropathy among dogs with chronic enteropathy in Japan. J Vet Med Sci 2016; 78:1377-80. [PMID: 27150023 PMCID: PMC5053946 DOI: 10.1292/jvms.15-0457] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
There have been limited reports on the prevalence of adverse food reactions among dogs
suffering from chronic enteropathy (CE) in Japan. We examined the prevalence and
histological features of food-responsive enteropathy (FRE) in a total of 32 dogs with
history of CE. Fourteen of 18 cases (56.2%) diagnosed as FRE had lymphocytic-plasmacytic
enteritis or eosinophilic enteritis by histopathological examination. Characteristic
histopathological changes indicating FRE were not identified in 18 cases, though 4 cases
did not show any abnormalities. Results collected from this study provided important
information that can help to change the way dogs with CE are treated in the future.
Collapse
Affiliation(s)
- Koji Kawano
- Primo Animal Hospital Nerima Animal Allergy Medical Center, Tokyo, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
128
|
Abstract
Lymphoma is one of the most common malignant tumors in canine. Protein phosphatase 2A (PP2A), a well-conserved serine/threonine phosphatase, plays a critical role as a tumor suppressor. Perphenazine (PPZ) is one of the phenothiazines and widely used as an antipsychotic drug. Recently, it is reported that PPZ directly binds with scaffolding subunit of PP2A complex and exerts anti-tumor effects on human T cell acute lymphoblastic leukemia. However, the effect of PPZ on canine lymphoma has not been studied. Here, we investigated the potential therapeutic role of PPZ and its molecular mechanism in canine T-cell lymphoma. In canine T-cell lymphoma cell lines, UL-1 and Ema, PPZ decreased cell survival in a dose-dependent manner. Increased caspase 3 activity and Annexin V positive cells suggested that PPZ induced apoptosis. PPZ dephosphorylated Akt, MEK1/2 and ERK1/2. Akt inhibitor, but not MEK1/2 inhibitor and ERK1/2 inhibitor, induced cell death, indicating the importance of Akt dephosphorylation for the anti-tumor effect of PPZ. Finally, we observed enhanced PP2A activity by PPZ treatment. The present results for the first time revealed that PPZ induced canine lymphoma cells apoptosis through Akt dephosphorylation via PP2A activation. Our study suggests the possible therapeutic application of phenothiazines for canine T-cell lymphoma.
Collapse
Affiliation(s)
- Shunya Tsuji
- Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
| | | | | | | | | | | |
Collapse
|
129
|
Nakamura Y, Suzuki R, Mizuno T, Abe K, Chiba S, Horii Y, Tsuboi J, Ito S, Obara W, Tanita T, Kanno H, Yamauchi K. Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma. Clin Exp Allergy 2016; 46:1152-61. [PMID: 26765219 DOI: 10.1111/cea.12710] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2015] [Revised: 12/31/2015] [Accepted: 01/05/2016] [Indexed: 02/01/2023]
Abstract
BACKGROUND Several gene variants identified in bronchial asthmatic patients are associated with a decrease in pulmonary function. The effects of this intervention on pulmonary function have not been fully researched. OBJECTIVE We determined the effects of high-dose inhaled corticosteroids (ICSs) on decreased pulmonary function in asthmatic Japanese patients with variants of IL13 and STAT4 during long-term treatments with low to mild doses of ICS. METHODS In this study, 411 patients with bronchial asthma who were receiving ICSs and living in Japan were recruited, were genotyped, and underwent pulmonary function tests and fibreoptic examinations. The effects of 2 years of high-dose ICSs administered to asthmatic patients who were homozygous for IL13 AA of rs20541 or STAT4 TT of rs925847 and who progressed to airway remodelling were investigated. RESULTS High-dose ICS treatment increased the pulmonary function of patients homozygous for IL13 AA of rs20541 but not of patients homozygous for STAT4 TT of rs925847. The increased concentrations of the mediators IL23, IL11, GMCSF, hyaluronic acid, IL24, and CCL8 in bronchial lavage fluid (BLF) were diminished after high-dose ICS treatment in patients homozygous for IL13 AA of rs20541. CONCLUSION AND CLINICAL RELEVANCE IL13 AA of rs20541 and STAT4 TT of rs925847 are potential genomic biomarkers for predicting lower pulmonary function. The administration of high-dose ICSs to asthmatic patients with genetic variants of IL13 AA may inhibit the advancement of airway remodelling. The genetic variants of STAT4 TT did not respond to high-dose ICSs. Therefore, using medications other than ICSs must be considered even during the initial treatment of bronchial asthma. These genetic variants may aid in the realization of personalized and phenotype-specific therapies for bronchial asthma.
Collapse
Affiliation(s)
- Y Nakamura
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| | - R Suzuki
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| | - T Mizuno
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| | - K Abe
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| | - S Chiba
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| | - Y Horii
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| | - J Tsuboi
- Department of Cardiovascular Surgery, Iwate Medical University School of Medicine, Morioka, Japan
| | - S Ito
- Department of Medical Oncology, Iwate Medical University School of Medicine, Morioka, Japan
| | - W Obara
- Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan
| | - T Tanita
- Department of Thoracic Surgery, Iwate Medical University School of Medicine, Morioka, Japan
| | - H Kanno
- Department of Pathology, Shinshu University School of Medicine, Matsumoto, Japan
| | - K Yamauchi
- Division of Pulmonary Medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
| |
Collapse
|
130
|
Shosu K, Sakurai M, Inoue K, Nakagawa T, Sakai H, Morimoto M, Okuda M, Noguchi S, Mizuno T. Programmed Cell Death Ligand 1 Expression in Canine Cancer. In Vivo 2016; 30:195-204. [PMID: 27107075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2016] [Accepted: 03/04/2016] [Indexed: 06/05/2023]
Abstract
BACKGROUND Antibody therapy targeting programmed cell death-1 (PD-1) and programmed cell death-ligand 1 (PD-L1) is a promising therapy in human cancer, but only limited information on PD-L1 expression in canine tumors is available. MATERIALS AND METHODS PD-L1 expression was examined in 31 canine tumor cell lines of various origins by flow cytometry and western blotting, and in canine tumor and normal tissue specimens by immunohistochemistry. RESULTS PD-L1 was only expressed on the cell surface of a small number of cell lines but was found expressed within the cells of almost all cell lines. Immunohistochemistry revealed that PD-L1 is frequently expressed in malignant melanoma, mammary gland tumor, mast cell tumor and lymphoma, but less frequently in soft-tissue sarcoma and hemangiosarcoma. PD-L1 was also expressed in some of the cells of normal canine tissue specimens. CONCLUSION Canine tumors with PD-L1 expression that were identified in this study are potential candidates for antiPD-1 and antiPD-L1 therapy.
Collapse
Affiliation(s)
- Kazuha Shosu
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan
| | - Masashi Sakurai
- Laboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan
| | - Kumi Inoue
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan
| | - Takayuki Nakagawa
- Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Hiroki Sakai
- Laboratory of Veterinary Pathology, Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan
| | - Masahiro Morimoto
- Laboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan
| | - Masaru Okuda
- Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan Biomedical Science Center for Translational Research, The United Graduate School of Veterinary Science, Yamaguchi University, Yoshida, Yamaguchi, Japan
| | - Shunsuke Noguchi
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan Biomedical Science Center for Translational Research, The United Graduate School of Veterinary Science, Yamaguchi University, Yoshida, Yamaguchi, Japan
| | - Takuya Mizuno
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan Biomedical Science Center for Translational Research, The United Graduate School of Veterinary Science, Yamaguchi University, Yoshida, Yamaguchi, Japan
| |
Collapse
|
131
|
Ajello M, Albert A, Anderson B, Baldini L, Barbiellini G, Bastieri D, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bottacini E, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cecchi C, Chekhtman A, Ciprini S, Cohen-Tanugi J, Conrad J, Costanza F, D'Ammando F, de Angelis A, de Palma F, Desiante R, Di Mauro M, Di Venere L, Domínguez A, Drell PS, Favuzzi C, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Glanzman T, Godfrey G, Guiriec S, Horan D, Jóhannesson G, Katsuragawa M, Kensei S, Kuss M, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lubrano P, Madejski GM, Maldera S, Manfreda A, Mayer M, Mazziotta MN, Meyer M, Michelson PF, Mirabal N, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Negro M, Nuss E, Okada C, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Sánchez-Conde M, Sgrò C, Simone D, Siskind EJ, Spada F, Spandre G, Spinelli P, Takahashi H, Thayer JB, Torres DF, Tosti G, Troja E, Uchiyama Y, Wood KS, Wood M, Zaharijas G, Zimmer S. Search for Spectral Irregularities due to Photon-Axionlike-Particle Oscillations with the Fermi Large Area Telescope. Phys Rev Lett 2016; 116:161101. [PMID: 27152783 DOI: 10.1103/physrevlett.116.161101] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2015] [Indexed: 06/05/2023]
Abstract
We report on the search for spectral irregularities induced by oscillations between photons and axionlike-particles (ALPs) in the γ-ray spectrum of NGC 1275, the central galaxy of the Perseus cluster. Using 6 years of Fermi Large Area Telescope data, we find no evidence for ALPs and exclude couplings above 5×10^{-12} GeV^{-1} for ALP masses 0.5≲m_{a}≲5 neV at 95% confidence. The limits are competitive with the sensitivity of planned laboratory experiments, and, together with other bounds, strongly constrain the possibility that ALPs can reduce the γ-ray opacity of the Universe.
Collapse
Affiliation(s)
- M Ajello
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, South Carolina 29634-0978, USA
| | - A Albert
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - B Anderson
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Baldini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - G Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - D Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei," Università di Padova, I-35131 Padova, Italy
| | - R Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R D Blandford
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - E D Bloom
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - R Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro," Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Bottacini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J Bregeon
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - P Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - G A Caliandro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - R A Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - M Caragiulo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P A Caraveo
- INAF-Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - C Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - A Chekhtman
- College of Science, George Mason University, Fairfax, Virginia 22030, USA and Naval Research Laboratory, Washington, D.C. 20375, USA
| | - S Ciprini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - J Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - J Conrad
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Costanza
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - F D'Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - A de Angelis
- Dipartimento di Fisica, Università di Udine and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine
| | - F de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - M Di Mauro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - L Di Venere
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - A Domínguez
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, South Carolina 29634-0978, USA
| | - P S Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - C Favuzzi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - W B Focke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - Y Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P Fusco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D Gasparrini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - N Giglietto
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - T Glanzman
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Guiriec
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - D Horan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - M Katsuragawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo-ku, Sagamihara, Kanagawa 252-5210, Japan
| | - S Kensei
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S Larsson
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - L Li
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F Loparco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - G M Madejski
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Maldera
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - A Manfreda
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M N Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - M Meyer
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - P F Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - N Mirabal
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - T Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M E Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata," I-00133 Roma, Italy
| | - I V Moskalenko
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Murgia
- Center for Cosmology, Physics and Astronomy Department, University of California, Irvine, California 92697-2575, USA
| | - M Negro
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro," Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - C Okada
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - E Orlando
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Denver, Colorado 80208, USA
| | - D Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J S Perkins
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M Pesce-Rollins
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - F Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - G Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - T A Porter
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Rainò
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - R Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei," Università di Padova, I-35131 Padova, Italy
| | - M Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - A Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - M Sánchez-Conde
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - C Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - D Simone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E J Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P Spinelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - H Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J B Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - D F Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - G Tosti
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E Troja
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Uchiyama
- Department of Physics, 3-34-1 Nishi-Ikebukuro, Toshima-ku, Tokyo 171-8501, Japan
| | - K S Wood
- Space Science Division, Naval Research Laboratory, Washington, D.C. 20375-5352, USA
| | - M Wood
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Zaharijas
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, and Università di Trieste, I-34127 Trieste, Italy
- Laboratory for Astroparticle Physics, University of Nova Gorica, Vipavska 13, SI-5000 Nova Gorica, Slovenia
| | - S Zimmer
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| |
Collapse
|
132
|
Ackermann M, Ajello M, Albert A, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bregeon J, Britto RJ, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cavazzuti E, Cecchi C, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Cohen-Tanugi J, Cominsky LR, Costanza F, Cutini S, D'Ammando F, de Angelis A, de Palma F, Desiante R, Digel SW, Di Mauro M, Di Venere L, Domínguez A, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giommi P, Giordano F, Giroletti M, Godfrey G, Green D, Grenier IA, Guiriec S, Hays E, Horan D, Iafrate G, Jogler T, Jóhannesson G, Kuss M, La Mura G, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Magill J, Maldera S, Manfreda A, Mayer M, Mazziotta MN, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Negro M, Nuss E, Ohsugi T, Okada C, Omodei N, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Petrosian V, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Reposeur T, Romani RW, Sánchez-Conde M, Schmid J, Schulz A, Sgrò C, Simone D, Siskind EJ, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Tibaldo L, Torres DF, Troja E, Vianello G, Yassine M, Zimmer S. Resolving the Extragalactic γ-Ray Background above 50 GeV with the Fermi Large Area Telescope. Phys Rev Lett 2016; 116:151105. [PMID: 27127954 DOI: 10.1103/physrevlett.116.151105] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2015] [Indexed: 05/16/2023]
Abstract
The Fermi Large Area Telescope (LAT) Collaboration has recently released a catalog of 360 sources detected above 50 GeV (2FHL). This catalog was obtained using 80 months of data re-processed with Pass 8, the newest event-level analysis, which significantly improves the acceptance and angular resolution of the instrument. Most of the 2FHL sources at high Galactic latitude are blazars. Using detailed Monte Carlo simulations, we measure, for the first time, the source count distribution, dN/dS, of extragalactic γ-ray sources at E>50 GeV and find that it is compatible with a Euclidean distribution down to the lowest measured source flux in the 2FHL (∼8×10^{-12} ph cm^{-2} s^{-1}). We employ a one-point photon fluctuation analysis to constrain the behavior of dN/dS below the source detection threshold. Overall, the source count distribution is constrained over three decades in flux and found compatible with a broken power law with a break flux, S_{b}, in the range [8×10^{-12},1.5×10^{-11}] ph cm^{-2} s^{-1} and power-law indices below and above the break of α_{2}∈[1.60,1.75] and α_{1}=2.49±0.12, respectively. Integration of dN/dS shows that point sources account for at least 86_{-14}^{+16}% of the total extragalactic γ-ray background. The simple form of the derived source count distribution is consistent with a single population (i.e., blazars) dominating the source counts to the minimum flux explored by this analysis. We estimate the density of sources detectable in blind surveys that will be performed in the coming years by the Cherenkov Telescope Array.
Collapse
Affiliation(s)
- M Ackermann
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M Ajello
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, SC 29634-0978, USA
| | - A Albert
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - W B Atwood
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, CA 95064, USA
| | - L Baldini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - J Ballet
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - G Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - D Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - K Bechtol
- Dept. of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin, Madison, WI 53706, USA
| | - R Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R D Blandford
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - E D Bloom
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - R Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro", Università degli Studi di Torino, I-10125 Torino, Italy
| | - J Bregeon
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - R J Britto
- Department of Physics, University of Johannesburg, PO Box 524, Auckland Park 2006, South Africa
| | - P Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - G A Caliandro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - R A Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Caragiulo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P A Caraveo
- INAF-Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - E Cavazzuti
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - C Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E Charles
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A Chekhtman
- College of Science, George Mason University, Fairfax, VA 22030, resident at Naval Research Laboratory, Washington, DC 20375, USA
| | - J Chiang
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - G Chiaro
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - S Ciprini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - J Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - L R Cominsky
- Department of Physics and Astronomy, Sonoma State University, Rohnert Park, CA 94928-3609, USA
| | - F Costanza
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - S Cutini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- INAF Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - F D'Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - A de Angelis
- Dipartimento di Fisica, Università di Udine and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine
| | - F de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - S W Digel
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Di Mauro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - L Di Venere
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - A Domínguez
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, SC 29634-0978, USA
| | - P S Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - C Favuzzi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - S J Fegan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - E C Ferrara
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - A Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - Y Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P Fusco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D Gasparrini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - N Giglietto
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P Giommi
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - F Giordano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - M Giroletti
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
| | - G Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - D Green
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - I A Grenier
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - S Guiriec
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- NASA Postdoctoral Program Fellow, USA
| | - E Hays
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - D Horan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Iafrate
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Osservatorio Astronomico di Trieste, Istituto Nazionale di Astrofisica, I-34143 Trieste, Italy
| | - T Jogler
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - G Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - M Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G La Mura
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - S Larsson
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - L Li
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F Loparco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - B Lott
- Centre d'Études Nucléaires de Bordeaux Gradignan, IN2P3/CNRS, Université Bordeaux 1, BP120, F-33175 Gradignan Cedex, France
| | - M N Lovellette
- Space Science Division, Naval Research Laboratory, Washington, DC 20375-5352, USA
| | - P Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - G M Madejski
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J Magill
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - S Maldera
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - A Manfreda
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M N Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - P F Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - T Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A A Moiseev
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
- Center for Research and Exploration in Space Science and Technology (CRESST) and NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M E Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata", I-00133 Roma, Italy
| | - I V Moskalenko
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - S Murgia
- Center for Cosmology, Physics and Astronomy Department, University of California, Irvine, California 92697-2575, USA
| | - M Negro
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro", Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - T Ohsugi
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - C Okada
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - N Omodei
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - E Orlando
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Denver, Colorado 80208, USA
| | - D Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J S Perkins
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - M Pesce-Rollins
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - V Petrosian
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - F Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - G Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - T A Porter
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - S Rainò
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - R Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - M Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
- Funded by contract FIRB-2012-RBFR12PM1F from the Italian Ministry of Education, University and Research (MIUR)
| | - S Razzaque
- Department of Physics, University of Johannesburg, PO Box 524, Auckland Park 2006, South Africa
| | - A Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - T Reposeur
- Centre d'Études Nucléaires de Bordeaux Gradignan, IN2P3/CNRS, Université Bordeaux 1, BP120, F-33175 Gradignan Cedex, France
| | - R W Romani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Sánchez-Conde
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - J Schmid
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - A Schulz
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - C Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - D Simone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E J Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P Spinelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - D J Suson
- Department of Chemistry and Physics, Purdue University Calumet, Hammond, Indiana 46323-2094, USA
| | - H Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J B Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - L Tibaldo
- Max-Planck-Institut für Kernphysik, D-69029 Heidelberg, Germany
| | - D F Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - E Troja
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - G Vianello
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Yassine
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - S Zimmer
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| |
Collapse
|
133
|
Suda S, Okubo S, Ueda M, Sowa K, Abe A, Aoki J, Muraga K, Suzuki K, Sakamoto Y, Mizuta I, Mizuno T, Kimura K. A Japanese CADASIL kindred with a novel two-baseNOTCH3mutation. Eur J Neurol 2016; 23:e32-4. [DOI: 10.1111/ene.12977] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2015] [Accepted: 01/18/2016] [Indexed: 11/29/2022]
Affiliation(s)
- S. Suda
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - S. Okubo
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - M. Ueda
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - K. Sowa
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - A. Abe
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - J. Aoki
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - K. Muraga
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - K. Suzuki
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - Y. Sakamoto
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| | - I. Mizuta
- Department of Neurology; Graduate School of Medical Science; Kyoto Prefectural University of Medicine; Kyoto Japan
| | - T. Mizuno
- Department of Neurology; Graduate School of Medical Science; Kyoto Prefectural University of Medicine; Kyoto Japan
| | - K. Kimura
- Department of Neurological Science; Graduate School of Medicine; Nippon Medical School; Tokyo Japan
| |
Collapse
|
134
|
Ackermann M, Ajello M, Albert A, Atwood WB, Baldini L, Barbiellini G, Bastieri D, Bellazzini R, Bissaldi E, Blandford RD, Bonino R, Bottacini E, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cavazzuti E, Cecchi C, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Costanza F, Cuoco A, Cutini S, D’Ammando F, de Angelis A, de Palma F, Desiante R, Digel SW, Di Venere L, Drell PS, Favuzzi C, Fegan SJ, Focke WB, Franckowiak A, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Harding AK, Hewitt JW, Horan D, Hou X, Iafrate G, Jóhannesson G, Kamae T, Kuss M, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lovellette MN, Lubrano P, Magill J, Maldera S, Manfreda A, Mayer M, Mazziotta MN, Michelson PF, Mitthumsiri W, Mizuno T, Monzani ME, Morselli A, Murgia S, Nuss E, Omodei N, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Petrosian V, Piron F, Pivato G, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Reposeur T, Sgrò C, Siskind EJ, Spada F, Spandre G, Spinelli P, Takahashi H, Thayer JB, Thompson DJ, Tibaldo L, Torres DF, Tosti G, Troja E, Vianello G, Winer BL, Wood KS, Yassine M, Cerutti F, Ferrari A, Sala PR. Measurement of the high-energy gamma-ray emission from the Moon with the Fermi Large Area Telescope. Phys Rev D 2016; 93:082001. [PMID: 32743154 PMCID: PMC7394319 DOI: 10.1103/physrevd.93.082001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
We have measured the gamma-ray emission spectrum of the Moon using the data collected by the Large Area Telescope onboard the Fermi satellite during its first seven years of operation, in the energy range from 30 MeV up to a few GeV. We have also studied the time evolution of the flux, finding a correlation with the solar activity. We have developed a full Monte Carlo simulation describing the interactions of cosmic rays with the lunar surface. The results of the present analysis can be explained in the framework of this model, where the production of gamma rays is due to the interactions of cosmic-ray proton and helium nuclei with the surface of the Moon. Finally, we have used our simulation to derive the cosmic-ray proton and helium spectra near Earth from the Moon gamma-ray data.
Collapse
Affiliation(s)
- M. Ackermann
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M. Ajello
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, South Carolina 29634-0978, USA
| | - A. Albert
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - W. B. Atwood
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, California 95064, USA
| | - L. Baldini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - G. Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - D. Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia “G. Galilei”, Università di Padova, I-35131 Padova, Italy
| | - R. Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E. Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R. D. Blandford
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - R. Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale “AmadeoAvogadro”, Università degli Studidi Torino, I-10125 Torino, Italy
| | - E. Bottacini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J. Bregeon
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | - P. Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, F-91128 Palaiseau Cedex, France
| | - R. Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - G. A. Caliandro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - R. A. Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - M. Caragiulo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P. A. Caraveo
- INAF-Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - E. Cavazzuti
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - C. Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - A. Chekhtman
- College of Science, George Mason University, Fairfax, Virginia 22030, USA and resident at Naval Research Laboratory, Washington, District of Columbia 20375, USA
| | - J. Chiang
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G. Chiaro
- Dipartimento di Fisica e Astronomia “G. Galilei”, Università di Padova, I-35131 Padova, Italy
| | - S. Ciprini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - R. Claus
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J. Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | - F. Costanza
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - A. Cuoco
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale “AmadeoAvogadro”, Università degli Studidi Torino, I-10125 Torino, Italy
| | - S. Cutini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- INAF Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - F. D’Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - A. de Angelis
- Dipartimento di Fisica, Università di Udine and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine
| | - F. de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R. Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - S. W. Digel
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - L. Di Venere
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P. S. Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - C. Favuzzi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - S. J. Fegan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, F-91128 Palaiseau Cedex, France
| | - W. B. Focke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A. Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S. Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P. Fusco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F. Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D. Gasparrini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - N. Giglietto
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F. Giordano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - M. Giroletti
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
| | - T. Glanzman
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G. Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - I. A. Grenier
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d’Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - J. E. Grove
- Space Science Division, Naval Research Laboratory, Washington, District of Columbia 20375-5352, USA
| | - S. Guiriec
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- NASA Postdoctoral Program Fellow, USA
| | - A. K. Harding
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - J. W. Hewitt
- Department of Physics, University of North Florida, 1 UNF Drive, Jacksonville, Florida 32224, USA
| | - D. Horan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, F-91128 Palaiseau Cedex, France
| | - X. Hou
- Yunnan Observatories, Chinese Academy of Sciences, Kunming 650216, China
- Key Laboratory for the Structure and Evolution of Celestial Objects, Chinese Academy of Sciences, Kunming 650216, China
| | - G. Iafrate
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Osservatorio Astronomico di Trieste, Istituto Nazionale di Astrofisica, I-34143 Trieste, Italy
| | - G. Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - T. Kamae
- Department of Physics, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - M. Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S. Larsson
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L. Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J. Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - L. Li
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F. Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F. Loparco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - M. N. Lovellette
- Space Science Division, Naval Research Laboratory, Washington, District of Columbia 20375-5352, USA
| | - P. Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - J. Magill
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - S. Maldera
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - A. Manfreda
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M. Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M. N. Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - P. F. Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - W. Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - T. Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M. E. Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A. Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma “Tor Vergata”, I-00133 Roma, Italy
| | - S. Murgia
- Center for Cosmology, Physics and Astronomy Department, University of California, Irvine, California 92697-2575, USA
| | - E. Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | - N. Omodei
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - E. Orlando
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J. F. Ormes
- Department of Physics and Astronomy, University of Denver, Denver, Colorado 80208, USA
| | - D. Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J. S. Perkins
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M. Pesce-Rollins
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - V. Petrosian
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - F. Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | - G. Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S. Rainò
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - R. Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia “G. Galilei”, Università di Padova, I-35131 Padova, Italy
| | - M. Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
- Funded by contract FIRB-2012-RBFR12PM1F from the Italian Ministry of Education, University and Research (MIUR)
| | - A. Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O. Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - T. Reposeur
- Centre d’Études Nucléaires de Bordeaux Gradignan, IN2P3/CNRS, Université Bordeaux 1, BP120, F-33175 Gradignan Cedex, France
| | - C. Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E. J. Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F. Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G. Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P. Spinelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - H. Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J. B. Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - D. J. Thompson
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - L. Tibaldo
- Max-Planck-Institut für Kernphysik, D-69029 Heidelberg, Germany
| | - D. F. Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), E-08010 Barcelona, Spain
| | - G. Tosti
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E. Troja
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - G. Vianello
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - B. L. Winer
- Department of Physics, Center for Cosmology and Astro-Particle Physics, The Ohio State University, Columbus, Ohio 43210, USA
| | - K. S. Wood
- Space Science Division, Naval Research Laboratory, Washington, District of Columbia 20375-5352, USA
| | - M. Yassine
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, F-34095 Montpellier, France
| | | | - F. Cerutti
- European Organization for Nuclear Research (CERN), CH-1211 Geneva, Switzerland
| | - A. Ferrari
- European Organization for Nuclear Research (CERN), CH-1211 Geneva, Switzerland
| | - P. R. Sala
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, I-20133 Milano, Italy
| |
Collapse
|
135
|
Ohshiro T, Miyagi C, Tamaki Y, Mizuno T, Ezaki T. Development of a rapid diagnostic method for identification of Staphylococcus aureus and antimicrobial resistance in positive blood culture bottles using a PCR-DNA-chromatography method. J Infect Chemother 2016; 22:372-6. [PMID: 27056092 DOI: 10.1016/j.jiac.2016.02.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2016] [Revised: 02/16/2016] [Accepted: 02/17/2016] [Indexed: 11/28/2022]
Abstract
Blood culturing and the rapid reporting of results are essential for infectious disease clinics to obtain bacterial information that can affect patient prognosis. When gram-positive coccoid cells are observed in blood culture bottles, it is important to determine whether the strain is Staphylococcus aureus and whether the strain has resistance genes, such as mecA and blaZ, for proper antibiotic selection. Previous work led to the development of a PCR method that is useful for rapid identification of bacterial species and antimicrobial susceptibility. However, that method has not yet been adopted in community hospitals due to the high cost and methodological complexity. We report here the development of a quick PCR and DNA-chromatography test, based on single-tag hybridization chromatography, that permits detection of S. aureus and the mecA and blaZ genes; results can be obtained within 1 h for positive blood culture bottles. We evaluated this method using 42 clinical isolates. Detection of S. aureus and the resistance genes by the PCR-DNA-chromatography method was compared with that obtained via the conventional identification method and actual antimicrobial susceptibility testing. Our method had a sensitivity of 97.0% and a specificity of 100% for the identification of the bacterial species. For the detection of the mecA gene of S. aureus, the sensitivity was 100% and the specificity was 95.2%. For the detection of the blaZ gene of S. aureus, the sensitivity was 100% and the specificity was 88.9%. The speed and simplicity of this PCR-DNA-chromatography method suggest that our method will facilitate rapid diagnoses.
Collapse
Affiliation(s)
- Takeya Ohshiro
- Division of Clinical Laboratory, Department of Medical Technology, Naha City Hospital, Okinawa, Japan; Department of Microbiology, Graduate School of Medicine Gifu University, Gifu, Japan.
| | - Chihiro Miyagi
- Division of Clinical Laboratory, Department of Medical Technology, Naha City Hospital, Okinawa, Japan
| | - Yoshikazu Tamaki
- Division of Clinical Laboratory, Department of Medical Technology, Naha City Hospital, Okinawa, Japan
| | - Takuya Mizuno
- Department of Microbiology, Graduate School of Medicine Gifu University, Gifu, Japan
| | - Takayuki Ezaki
- Department of Microbiology, Graduate School of Medicine Gifu University, Gifu, Japan
| |
Collapse
|
136
|
|
137
|
Sagara Y, Sawaki M, Taira N, Saito T, Kashiwaba M, Iwata H, Kobayashi K, Nakayama T, Bando H, Mizuno T, Yamamoto Y, Tsuneizumi M, Takahashi M, Yamaguchi M, Kawashima H, Takashima T, Uemura Y, Hozumi Y, Sagawa N, Mukai H, Ohashi Y. Abstract P5-18-01: A randomized clinical trial of postoperative adjuvant therapy for elderly breast cancer patients: Conditions of obtaining informed consent and reasons for declining participation. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p5-18-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: There are few randomized clinical trials examining adjuvant treatment in elderly breast cancer patients. While obtaining informed consent is essential for participation in clinical studies, there is little information on the frequency of agreement to participate among elderly patients. Furthermore, elderly patients might have specific reasons to decline participation.
Patients and Method: The National Surgical Adjuvant Study of Breast Cancer 07 (N-SAS BC 07) is a randomized clinical trial in women over 70 years with HER2-positive primary breast cancer. The primary aim was to investigate the benefit of trastuzumab monotherapy compared with the combination of trastuzumab and chemotherapy. Key inclusion criteria were as follows: women between 70 and 80 years old with HER2-positive breast cancer; underwent curative operation; stage I to IIIA; with sufficient organ function. Patients were randomized to receive either trastuzumab plus chemotherapy or trastuzumab monotherapy. The primary endpoint was disease-free survival, and the secondary endpoints were overall survival, relapse-free survival, safety, health-related quality of life, and cost effectiveness (NCT01104935). It was not possible to predict the number of patients who would agree to participate. In order to comprehensively assess the effect of postoperative adjuvant therapy, we evaluated the reasons why eligible patients declined to participate. The patients were registered in a cohort study to prospectively evaluate the subsequent treatment options and prognosis (07-Cohort). This study examined the obtaining of informed consent for N-SAS BC 07 and the reasons for declining participation, and compared the clinicopathological backgrounds between the N-SAS BC 07 and 07-Cohort groups.
Results: 398 eligible patients have been recruited. Informed consent to participate in N-SAS BC 07 has been obtained from 275 patients (69%) and 123 patients (31%) who declined to participate in the RCT have been registered in the 07-Cohort. The common reasons to decline participation in the RCT were "cannot choose the treatment option (55%)", "refused chemotherapy (16%)", "wanted chemotherapy (9%)", "anxious about clinical studies (9%)" and "family opposition (8%)". The mean ages of the patients in N-SAS BC 07 and 07-Cohort were 73.9 and 74.6 years old, respectively. There were no differences in stage, surgical procedure, lymph node metastasis, or co-morbidities between the groups. ER-positive rate was higher in 07-Cohort group compared with N-SAS BC 07 group (53% vs. 37%, p=0.017, χ2 test).
Conclusion: While we expected the number of registrants to be small, since N-SAS BC 07 investigated whether elderly patients with HER2-positive breast cancer should undergo chemotherapy, almost 70% of the patients accepted informed consent. The most common reason to decline participation in N-SAS BC 07 was "cannot choose the treatment option" and the majority refused chemotherapy. Furthermore, ER-positivity was higher in the 07-Cohort group, which suggested that ER expression in the patients with HER2-positive breast cancer might influence their decision to participate in the study or to choose the treatment option.
Citation Format: Sagara Y, Sawaki M, Taira N, Saito T, Kashiwaba M, Iwata H, Kobayashi K, Nakayama T, Bando H, Mizuno T, Yamamoto Y, Tsuneizumi M, Takahashi M, Yamaguchi M, Kawashima H, Takashima T, Uemura Y, Hozumi Y, Sagawa N, Mukai H, Ohashi Y. A randomized clinical trial of postoperative adjuvant therapy for elderly breast cancer patients: Conditions of obtaining informed consent and reasons for declining participation. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P5-18-01.
Collapse
Affiliation(s)
- Y Sagara
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - M Sawaki
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - N Taira
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - T Saito
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - M Kashiwaba
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - H Iwata
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - K Kobayashi
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - T Nakayama
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - H Bando
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - T Mizuno
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - Y Yamamoto
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - M Tsuneizumi
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - M Takahashi
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - M Yamaguchi
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - H Kawashima
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - T Takashima
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - Y Uemura
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - Y Hozumi
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - N Sagawa
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - H Mukai
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| | - Y Ohashi
- Hakuaikai Social Cooperation, Kagoshima, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Saitama Red Cross Hospital, Saitama, Japan; Iwate Medical University, Morioka, Iwate, Japan; Okayama University Hospital, Okayama, Japan; Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; Kumamoto University, Kumamoto, Japan; Shizuoka General Hospital, Shizuoka, Japan; Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Kurume General Hospital, Kurume, Fukuoka, Japan; Aomori City Hospital, Aomori, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Tokyo University Hospital, Tokyo, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Chuo University, Tokyo, Japan
| |
Collapse
|
138
|
Ishihara M, Tamaru S, Oda H, Yamashita Y, Tono Y, Mizuno T, Katayama N. Abstract P4-13-21: A pilot study of pertuzumab, trastuzumab and eribulin for patients with advanced HER2 positive breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p4-13-21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
[Introduction] The triple therapy of pertuzumab, trastuzumab and taxanes (docetaxel or paclitaxel) is coming into widespread use, because of the beneficial effects on HER2 positive breast cancer. However, we don't have enough information about the efficacy and safety of other agents with trastuzumab and pertuzumab (TP). We studied triple therapy of pertuzumab, trastuzumab and eribulin (PTE) for advanced HER2 positive breast cancer to assess the efficacy, safety and QOL prospectively (UMIN000012018).
[Patients and methods] Responses were assessed by RECIST criteria v1.1. Adverse events (AEs) were graded according to CTCAE v4.0. Patients with advanced HER2 positive breast cancer were treated with pertuzumab (840 mg loading then 420 mg, day 1), trastuzumab (8 mg/kg loading then 6 mg/kg, day 1), and eribulin (1.4 mg/m2, day 1 and 8) every 3 weeks. Dose reduction was allowed when patients developed febrile neutropenia, grade 3-5 non-hematologic toxicity or skipped day 8 eribulin administration because of neutrophil count <1000/mm3. QOL was assessed using FACT-B at baseline and 3 months after initial treatment.
[Results] Ten patients were enrolled. Median age of patients was 60 years-old (35-75). Median number of prior chemoregimen for metastatic disease was 3 (0-5). Two patients had a history of docetaxel allergy. Median number of PTE cycle was 6 (3-12). Eight patients reduced eribulin doses 1.4 mg/m2 to 1.1 mg/m2 because of AEs (2 patients), skipped day 8 eribulin (4 patients), or physician's choice (2 patients). One complete response, 1 partial response and 5 stable disease were achieved at 3 months. Two patients (1 CR and 1 SD) stopped eribulin and received TP as maintenance therapy. At 3 months, all 3 patients with progressive disease developed brain metastasis. Two patients had extracranial progressive lesions, but 1 patient had partial response for extracranial disease.
The common treatment-related AEs were leukopenia, neutropenia, lymphopenia diarrhea, hypokalemia and stomatitis. Grade 3 AEs were leukopenia (7 patients), neutropenia (8 patients), lymphopenia (2 patients), febrile neutropenia (1 patient), hypokalemia (1 patient) and peripheral neuropathy (1 patient). Grade 4/5 AEs were not observed.
Nine patients could be assessed QOL. FACT-B TOI, FACT-G and FACT-B total score had a tendency to be improved at 3 months.
[Conclusion] The PTE therapy showed appropriate clinical effect for extracranial lesions and maintained QOL of patients with advanced HER2 positive breast cancer. It may be a choice for patients who have taxane-resistant diseases or a history of taxane allergy.
Many patients needed to reduce eribulin dosage. When the PTE therapy is referred to advanced HER2 positive breast cancer patients as a palliative chemotherapy, eribulin (1.1mg/m2) might be a reasonable dosage.
Citation Format: Ishihara M, Tamaru S, Oda H, Yamashita Y, Tono Y, Mizuno T, Katayama N. A pilot study of pertuzumab, trastuzumab and eribulin for patients with advanced HER2 positive breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P4-13-21.
Collapse
Affiliation(s)
- M Ishihara
- Mie University Hospital, Tsu, Mie, Japan
| | - S Tamaru
- Mie University Hospital, Tsu, Mie, Japan
| | - H Oda
- Mie University Hospital, Tsu, Mie, Japan
| | | | - Y Tono
- Mie University Hospital, Tsu, Mie, Japan
| | - T Mizuno
- Mie University Hospital, Tsu, Mie, Japan
| | - N Katayama
- Mie University Hospital, Tsu, Mie, Japan
| |
Collapse
|
139
|
Saito T, Sawaki M, Hozumi Y, Sagawa N, Iwata H, Kashiwaba M, Kawashima H, Kobayashi K, Taira N, Takashima T, Takahashi M, Tsuneizumi M, Nakayama T, Baba S, Bando H, Mizuno T, Yamaguchi M, Yamamoto Y, Uemura Y, Ohashi Y, Mukai H. Abstract P4-11-09: A randomized controlled trial of postoperative adjuvant therapy for elderly breast cancer patients: Comparison of health-related quality of life between clinical trial participants and decliners. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p4-11-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Health-related quality of life (HRQoL) is one of the important outcomes in cancer control trials and has increasingly become the one of the primary foci. Obtaining informed consent from participants is essential for participation in randomized controlled trials (RCTs), but the participation in these RCTs may directly influence HRQoL, because treatment options are determined according to the allocation schedule. To date, only a few studies have compared HRQoL between clinical trial participants and decliners.
Patients and Method: The National Surgical Adjuvant Study of Breast Cancer 07 (N-SAS BC 07) is a randomized controlled trial in women with HER2-positive primary breast cancer who are over 70 years of age. The primary aim was to investigate the benefit of trastuzumab monotherapy compared with combination therapy using trastuzumab and chemotherapy. The study concept and design were published in concept paper (Sawaki M. et al., Jpn J Clin Oncol. 2011). In this study, patients were randomized to receive either trastuzumab plus chemotherapy or trastuzumab monotherapy. The primary endpoint was disease-free survival, and the secondary endpoints were overall survival, relapse-free survival, safety, HRQoL, comprehensive geriatric assessment (CGA) and cost effectiveness (protocol ID; NCT01104935).
HRQoL and CGA were assessed at registration (baseline), 2 month, 1 year, and 3 years after the start of protocol treatments using the Functional Assessment of Cancer Therapy-General (FACT-G), Hospital Anxiety and Depression Scale (HADS), EuroQol 5 Dimension (EQ-5D), Tokyo Metropolitan Institute of Gerontology (TMIG) index of competence, and the Philadelphia Geriatric Center (PGC) Morale Scale.
The patients who declined to participate in N-SAS BC 07 were registered in a cohort study to prospectively evaluate the subsequent treatment options and prognosis (07-Cohort). The same questionnaire that was used in N-SAS BC 07 was used in 07-Cohort to evaluate HRQoL and CGA at entry.
Results: Patients were enrolled from October 2012 to October 2016. During this period, 275 and 123 patients were registered in N-SAS BC 07 and 07-Cohort, respectively. The mean age at entry of the patients in the N-SAS BC 07 and 07-Cohort groups was 73.9 and 74.6 years, respectively. The questionnaire response rates at baseline in the patients in N-SAS BC 07 and 07-Cohort groups were 89% and 82%, respectively. There were no significant differences in FACT-G, HADS, EQ-5D, or TMIG index of competence at baseline between the groups, but the mean (standard deviation) scores of PGC Morale Scale in N-SAS BC 07 and 07-Cohort groups were 10.8 (3.3) and 9.9 (3.7), respectively, with the scores being significantly greater in the N-SAS BC 07 group (p=0.020, t-test).
Conclusion: The PGC Morale Scale provides a multidimensional approach to assess the psychological state of older people. This study indicated that participation in the RCT did not affect the baseline QoL of elderly patients but suggested that the baseline QoL of the RCT participants was better than decliners.
Citation Format: Saito T, Sawaki M, Hozumi Y, Sagawa N, Iwata H, Kashiwaba M, Kawashima H, Kobayashi K, Taira N, Takashima T, Takahashi M, Tsuneizumi M, Nakayama T, Baba S, Bando H, Mizuno T, Yamaguchi M, Yamamoto Y, Uemura Y, Ohashi Y, Mukai H. A randomized controlled trial of postoperative adjuvant therapy for elderly breast cancer patients: Comparison of health-related quality of life between clinical trial participants and decliners. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P4-11-09.
Collapse
Affiliation(s)
- T Saito
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - M Sawaki
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - Y Hozumi
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - N Sagawa
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - H Iwata
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - M Kashiwaba
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - H Kawashima
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - K Kobayashi
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - N Taira
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - T Takashima
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - M Takahashi
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - M Tsuneizumi
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - T Nakayama
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - S Baba
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - H Bando
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - T Mizuno
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - M Yamaguchi
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - Y Yamamoto
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - Y Uemura
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - Y Ohashi
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| | - H Mukai
- Saitama Red Cross Hospital, Saitama, Japan; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan; Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan; Kameda Medical Center, Kamogawa, Chiba, Japan; Iwate Medical University, Mrioka, Iwate, Japan; Aomori City Hospital, Aomori, Japan; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan; Okayama University Hospital, Okayama, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan; Shizuoka General Hospital, Shizuoka, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Mie University Hospital, Tsu, Mie, Japan; JCHO Kurume General Hospital, Kurume, Fukuoka, Japan; Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Tokyo University Hospital, Bunkyo-ku, Tokyo, Japan; Chuo University, Bunkyo-ku, Tokyo, Japan; National Cancer Center Hospital East,
| |
Collapse
|
140
|
Chidambaran V, Venkatasubramanian R, Zhang X, Martin LJ, Niu J, Mizuno T, Fukuda T, Meller J, Vinks AA, Sadhasivam S. ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children. Pharmacogenomics J 2016; 17:162-169. [PMID: 26810133 PMCID: PMC4959996 DOI: 10.1038/tpj.2015.98] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/26/2015] [Revised: 11/04/2015] [Accepted: 11/13/2015] [Indexed: 02/07/2023]
Abstract
Respiratory depression (RD) is a serious side effect of morphine and detrimental to effective analgesia. We reported that variants of the ATP binding cassette gene ABCC3 (facilitates hepatic morphine metabolite efflux) affect morphine metabolite clearance. In this study of 316 children undergoing tonsillectomy, we found significant association between ABCC3 variants and RD leading to prolonged postoperative care unit stay (prolonged RD). Allele A at rs4148412 and allele G at rs729923 caused a 2.36 (95% CI=1.28-4.37, P=0.0061) and 3.7 (95% CI 1.47-9.09, P=0.0050) times increase in odds of prolonged RD, respectively. These clinical associations were supported by increased formation clearance of morphine glucuronides in children with rs4148412 AA and rs4973665 CC genotypes in this cohort, as well as an independent spine surgical cohort of 67 adolescents. This is the first study to report association of ABCC3 variants with opioid-related RD, and morphine metabolite formation (in two independent surgical cohorts).
Collapse
Affiliation(s)
- V Chidambaran
- Department of Anesthesia, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA
| | - R Venkatasubramanian
- Department of Anesthesia, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - X Zhang
- Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - L J Martin
- Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - J Niu
- Department of Anesthesia, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - T Mizuno
- Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - T Fukuda
- Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - J Meller
- Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Division of Bioinformatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - A A Vinks
- Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - S Sadhasivam
- Department of Anesthesia, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.,Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA
| |
Collapse
|
141
|
Igase M, Hwang CC, Kambayashi S, Kubo M, Coffey M, Miyama TS, Baba K, Okuda M, Noguchi S, Mizuno T. Oncolytic reovirus synergizes with chemotherapeutic agents to promote cell death in canine mammary gland tumor. Can J Vet Res 2016; 80:21-31. [PMID: 26733729 PMCID: PMC4686031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/08/2015] [Accepted: 06/17/2015] [Indexed: 06/05/2023]
Abstract
The oncolytic effects of reovirus in various cancers have been proven in many clinical trials in human medicine. Oncolytic virotherapy using reovirus for canine cancers is being developed in our laboratory. The objective of this study was to examine the synergistic anti-cancer effects of a combination of reovirus and low doses of various chemotherapeutic agents on mammary gland tumors (MGTs) in dogs. The first part of this study demonstrated the efficacy of reovirus in canine MGTs in vitro and in vivo. Reovirus alone exerted significant cell death by means of caspase-dependent apoptosis in canine MGT cell lines. A single injection of reovirus impeded growth of canine MGT tumors in xenografted mice, but was insufficient to induce complete tumor regression. The second part of this study highlighted the anti-tumor effects of reovirus in combination with low doses of paclitaxel, carboplatin, gemcitabine, or toceranib. Enhanced synergistic activity was observed in the MGT cell line treated concomitantly with reovirus and in all the chemotherapeutic agents except toceranib. In addition, combining reovirus with paclitaxel or gemcitabine at half dosage of half maximal inhibitory concentration (IC50) enhanced cytotoxicity by activating caspase 3. Our data suggest that the combination of reovirus and low dose chemotherapeutic agents provides an attractive option in canine cancer therapy.
Collapse
Affiliation(s)
- Masaya Igase
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Chung Chew Hwang
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Satoshi Kambayashi
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Masato Kubo
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Matt Coffey
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Takako Shimokawa Miyama
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Kenji Baba
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Masaru Okuda
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Shunsuke Noguchi
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| | - Takuya Mizuno
- Laboratory of Molecular Diagnostics and Therapeutics (Igase, Noguchi, Mizuno), Laboratory of Veterinary Internal Medicine (Kambayashi, Miyama, Baba, Okuda), and Laboratory of Veterinary Pathology (Kubo), Joint Faculty of Veterinary Medicine and Laboratory of Molecular Diagnostics and Therapeutics (Hwang) and Biomedical Science Center for Translational Research (Okuda, Noguchi, Mizuno), United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan; Oncolytics Biotech Inc., Calgary, Alberta (Coffey)
| |
Collapse
|
142
|
Chauvin M, Florén HG, Jackson M, Kamae T, Kawano T, Kiss M, Kole M, Mikhalev V, Moretti E, Olofsson G, Rydström S, Takahashi H, Iyudin A, Arimoto M, Fukazawa Y, Kataoka J, Kawai N, Mizuno T, Ryde F, Tajima H, Takahashi T, Pearce M. Observation of polarized hard X-ray emission from the Crab by thePoGOLite Pathfinder. ACTA ACUST UNITED AC 2015. [DOI: 10.1093/mnrasl/slv177] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
143
|
Ackermann M, Albert A, Anderson B, Atwood WB, Baldini L, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caputo R, Caragiulo M, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cuoco A, Cutini S, D'Ammando F, de Angelis A, de Palma F, Desiante R, Digel SW, Di Venere L, Drell PS, Drlica-Wagner A, Essig R, Favuzzi C, Fegan SJ, Ferrara EC, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Gomez-Vargas GA, Grenier IA, Guiriec S, Gustafsson M, Hays E, Hewitt JW, Horan D, Jogler T, Jóhannesson G, Kuss M, Larsson S, Latronico L, Li J, Li L, Llena Garde M, Longo F, Loparco F, Lubrano P, Malyshev D, Mayer M, Mazziotta MN, McEnery JE, Meyer M, Michelson PF, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Murgia S, Nuss E, Ohsugi T, Orienti M, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Ritz S, Sánchez-Conde M, Schulz A, Sehgal N, Sgrò C, Siskind EJ, Spada F, Spandre G, Spinelli P, Strigari L, Tajima H, Takahashi H, Thayer JB, Tibaldo L, Torres DF, Troja E, Vianello G, Werner M, Winer BL, Wood KS, Wood M, Zaharijas G, Zimmer S. Searching for Dark Matter Annihilation from Milky Way Dwarf Spheroidal Galaxies with Six Years of Fermi Large Area Telescope Data. Phys Rev Lett 2015; 115:231301. [PMID: 26684107 DOI: 10.1103/physrevlett.115.231301] [Citation(s) in RCA: 72] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Indexed: 06/05/2023]
Abstract
The dwarf spheroidal satellite galaxies (dSphs) of the Milky Way are some of the most dark matter (DM) dominated objects known. We report on γ-ray observations of Milky Way dSphs based on six years of Fermi Large Area Telescope data processed with the new Pass8 event-level analysis. None of the dSphs are significantly detected in γ rays, and we present upper limits on the DM annihilation cross section from a combined analysis of 15 dSphs. These constraints are among the strongest and most robust to date and lie below the canonical thermal relic cross section for DM of mass ≲100 GeV annihilating via quark and τ-lepton channels.
Collapse
Affiliation(s)
- M Ackermann
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - A Albert
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - B Anderson
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - W B Atwood
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, California 95064, USA
| | - L Baldini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - G Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - D Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - K Bechtol
- Dept. of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - R Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R D Blandford
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - E D Bloom
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - R Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro", Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Bottacini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - T J Brandt
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - J Bregeon
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - P Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - G A Caliandro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - R A Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - R Caputo
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, California 95064, USA
| | - M Caragiulo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - P A Caraveo
- INAF-Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - C Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E Charles
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Chekhtman
- College of Science, George Mason University, Fairfax, Virginia 22030, USA
| | - J Chiang
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Chiaro
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - S Ciprini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- INAF Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - R Claus
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - J Conrad
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Wallenberg Academy Fellow
| | - A Cuoco
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro", Università degli Studi di Torino, I-10125 Torino, Italy
| | - S Cutini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- INAF Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - F D'Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - A de Angelis
- Dipartimento di Fisica, Università di Udine and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine
| | - F de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - S W Digel
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - L Di Venere
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P S Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Drlica-Wagner
- Center for Particle Astrophysics, Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Essig
- C.N. Yang Institute for Theoretical Physics, State University of New York, Stony Brook, New York 11794-3840, USA
| | - C Favuzzi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - S J Fegan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - E C Ferrara
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - W B Focke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - Y Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P Fusco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D Gasparrini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- INAF Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - N Giglietto
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F Giordano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - M Giroletti
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
| | - T Glanzman
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G A Gomez-Vargas
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata", I-00133 Roma, Italy
- Departamento de Fisíca, Pontificia Universidad Católica de Chile, Avenida Vicuña Mackenna 4860, Santiago, Chile
| | - I A Grenier
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - S Guiriec
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- NASA Postdoctoral Program Fellow, USA
| | - M Gustafsson
- Georg-August University Göttingen, Institute for theoretical Physics-Faculty of Physics, Friedrich-Hund-Platz 1, D-37077 Göttingen, Germany
| | - E Hays
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - J W Hewitt
- University of North Florida, Department of Physics, 1 UNF Drive, Jacksonville, Florida 32224, USA
| | - D Horan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - T Jogler
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - M Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S Larsson
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - L Li
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
| | - M Llena Garde
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F Loparco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - D Malyshev
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - M Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M N Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - J E McEnery
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Meyer
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - P F Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - T Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A A Moiseev
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
- Center for Research and Exploration in Space Science and Technology (CRESST) and NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M E Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata", I-00133 Roma, Italy
| | - S Murgia
- Center for Cosmology, Physics and Astronomy Department, University of California, Irvine, California 92697-2575, USA
| | - E Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - T Ohsugi
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M Orienti
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
| | - E Orlando
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Denver, CO 80208, USA
| | - D Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J S Perkins
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M Pesce-Rollins
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - F Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - G Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - T A Porter
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Rainò
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - R Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - M Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - A Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - S Ritz
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, California 95064, USA
| | - M Sánchez-Conde
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - A Schulz
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - N Sehgal
- Physics and Astronomy Department, Stony Brook University, Stony Brook, New York 11794, USA
| | - C Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E J Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P Spinelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - L Strigari
- Texas A&M University, Department of Physics and Astronomy, College Station, Texas 77843-4242, USA
| | - H Tajima
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya 464-8601, Japan
| | - H Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J B Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - L Tibaldo
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - D F Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - E Troja
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - G Vianello
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - M Werner
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - B L Winer
- Department of Physics, Center for Cosmology and Astro-Particle Physics, The Ohio State University, Columbus, Ohio 43210, USA
| | - K S Wood
- Space Science Division, Naval Research Laboratory, Washington, DC 20375-5352, USA
| | - M Wood
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Zaharijas
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, and Università di Trieste, I-34127 Trieste, Italy
- Laboratory for Astroparticle Physics, University of Nova Gorica, Vipavska 13, SI-5000 Nova Gorica, Slovenia
| | - S Zimmer
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| |
Collapse
|
144
|
Igase M, Shimokawa Miyama T, Kambayashi S, Shimoyama Y, Hiraoka H, Hirata Y, Iwata M, Baba K, Mizuno T, Okuda M. Bimodal immunoglobulin A gammopathy in a cat with feline myeloma-related disorders. J Vet Med Sci 2015; 78:691-5. [PMID: 26638898 PMCID: PMC4873863 DOI: 10.1292/jvms.15-0156] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
A 10-year-old female spayed mixed breed cat with a subcutaneous mass on the right hind
limb was revealed with bimodal monoclonal gammopathy composed of IgA by
immunoelectrophoresis and immunofixation. Approximately 1 month after referral, the cat
died due to renal failure. Postmortem immunohistopathologic evaluation of the subcutaneous
mass revealed neoplastic cell proliferation of plasma cells and giant myeloma cells.
Neoplastic cells were also present in the liver and spleen. These results led to the
diagnosis of a rare case of feline myeloma-related disorders with extramedullary
plasmacytoma infiltrating in multiple locations. This report emphasizes the necessity to
accumulate cases with similar clinicopathologic findings in the future.
Collapse
Affiliation(s)
- Masaya Igase
- Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
145
|
Noguchi S, Mori T, Igase M, Mizuno T. A novel apoptosis-inducing mechanism of 5-aza-2′-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1. Cancer Lett 2015; 369:344-53. [DOI: 10.1016/j.canlet.2015.08.023] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Revised: 08/19/2015] [Accepted: 08/24/2015] [Indexed: 10/23/2022]
|
146
|
Kuroda H, Seto K, Yoshida T, Mizuno T, Sakakura N, Hida T, Yatabe Y, Sakao Y. 474P Effects of smoking habit in NSCLC with KRAS mutation in pathological stage I. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv532.58] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
147
|
Ackermann M, Albert A, Baldini L, Ballet J, Barbiellini G, Barbieri C, Bastieri D, Bellazzini R, Bissaldi E, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Cohen-Tanugi J, Cuoco A, Cutini S, D’Ammando F, Desiante FDPR, Digel SW, Di Venere L, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Franckowiak A, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Godfrey G, Grenier IA, Grondin MH, Grove JE, Guillemot L, Guiriec S, Hagiwara K, Harding AK, Hays E, Hewitt JW, Hill AB, Horan D, Johnson TJ, Knödlseder J, Kuss M, Larsson S, Latronico L, Lemoine-Goumard M, Li J, Li L, Longo F, Loparco F, Lovellette MN, Lubrano P, Maldera S, Manfreda A, Marshall F, Martin P, Mayer M, Mazziotta MN, Michelson PF, Mirabal N, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Naletto G, Nuss E, Ohsugi T, Orienti M, Orlando E, Paneque D, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Reposeur T, Romani RW, Parkinson PMS, Schulz A, Sgrò C, Siskind EJ, Smith DA, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Thompson DJ, Tibaldo L, Torres DF, Uchiyama Y, Vianello G, Wood KS, Wood M, Zampieri L. An extremely bright gamma-ray pulsar in the Large Magellanic Cloud. Science 2015; 350:801-5. [DOI: 10.1126/science.aac7400] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
148
|
Miyatani F, Kuriyama N, Watanabe I, Nomura R, Nakano K, Matsui D, Ozaki E, Koyama T, Nishigaki M, Yamamoto T, Mizuno T, Tamura A, Akazawa K, Takada A, Takeda K, Yamada K, Nakagawa M, Ihara M, Kanamura N, Friedland RP, Watanabe Y. Relationship between Cnm-positive Streptococcus mutans and cerebral microbleeds in humans. Oral Dis 2015. [PMID: 26205098 DOI: 10.1111/odi.12360] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Cerebral hemorrhage has been shown to occur in animals experimentally infected with Streptococcus mutans carrying the collagen-binding Cnm gene. However, the relationship between cerebral microbleeds and oral hygiene, with a focus on Cnm gene-positive S. mutans infection, remains unclear. MATERIAL AND METHODS One hundred and thirty-nine subjects participated. The presence or absence of Cnm-positive S. mutans and its collagen-binding activity were investigated using saliva samples, and relationship with cerebral microbleeds detected on MRI investigated, including clinical information and oral parameters. RESULTS Fifty-one subjects were identified as Cnm-positive S. mutans carriers (36.7%), with cerebral microbleeds being detected in 43 (30.9%). A significantly larger number of subjects carried Cnm-positive S. mutans in the cerebral microbleeds (+) group. S. mutans with Cnm collagen-binding ability was detected in 39 (28.1%) of all subjects, and the adjusted odds ratio for cerebral microbleeds in the Cnm-positive group was 14.4. Regarding the presence of cerebral microbleeds, no significant differences were noted in the number of remaining teeth, dental caries, or in classic arteriosclerosis risk factors. CONCLUSIONS The occurrence of cerebral microbleeds was higher in subjects carrying Cnm-positive S. mutans, indicating that the presence of Cnm-positive S. mutans increases cerebral microbleeds, and is an independent risk for the development of cerebrovascular disorders.
Collapse
Affiliation(s)
- F Miyatani
- Departments of Dental Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.,Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - N Kuriyama
- Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.,Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - I Watanabe
- Departments of Dental Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.,Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - R Nomura
- Department of Pediatric Dentistry, Osaka University Graduate School of Dentistry, Osaka, Japan
| | - K Nakano
- Department of Pediatric Dentistry, Osaka University Graduate School of Dentistry, Osaka, Japan
| | - D Matsui
- Departments of Dental Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.,Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - E Ozaki
- Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - T Koyama
- Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - M Nishigaki
- Departments of Dental Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - T Yamamoto
- Departments of Dental Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - T Mizuno
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - A Tamura
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - K Akazawa
- Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - A Takada
- Kyoto Industrial Health Association, Kyoto, Japan
| | - K Takeda
- Kyoto Industrial Health Association, Kyoto, Japan
| | - K Yamada
- Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - M Nakagawa
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - M Ihara
- Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, Osaka, Japan
| | - N Kanamura
- Departments of Dental Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - R P Friedland
- Department of Neurology, University of Louisville, KY, USA
| | - Y Watanabe
- Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
| |
Collapse
|
149
|
Ackermann M, Ajello M, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Gonzalez JB, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Britto RJ, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Carpenter B, Casandjian JM, Cavazzuti E, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Cominsky LR, Conrad J, Cutini S, D’Abrusco R, D’Ammando F, Angelis AD, Desiante R, Digel SW, Venere LD, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Finke J, Focke WB, Franckowiak A, Fuhrmann L, Fukazawa Y, Furniss AK, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giommi P, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Hewitt JW, Hill AB, Horan D, Itoh R, Jóhannesson G, Johnson AS, Johnson WN, Kataoka J, Kawano T, Krauss F, Kuss M, Mura GL, Larsson S, Latronico L, Leto C, Li J, Li L, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Mayer M, Mazziotta MN, McEnery JE, Michelson PF, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nuss E, Ohno M, Ohsugi T, Ojha R, Omodei N, Orienti M, Orlando E, Paggi A, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Romani RW, Salvetti D, Schaal M, Schinzel FK, Schulz A, Sgrò C, Siskind EJ, Sokolovsky KV, Spada F, Spandre G, Spinelli P, Stawarz L, Suson DJ, Takahashi H, Takahashi T, Tanaka Y, Thayer JG, Thayer JB, Tibaldo L, Torres DF, Torresi E, Tosti G, Troja E, Uchiyama Y, Vianello G, Winer BL, Wood KS, Zimmer S. THE THIRD CATALOG OF ACTIVE GALACTIC NUCLEI DETECTED BY THEFERMILARGE AREA TELESCOPE. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/810/1/14] [Citation(s) in RCA: 424] [Impact Index Per Article: 47.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
150
|
Clark CJ, Pletsch HJ, Wu J, Guillemot L, Ackermann M, Allen B, Angelis AD, Aulbert C, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bellazzini R, Bissaldi E, Bock O, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buson S, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cecchi C, Champion DJ, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Cuéllar A, Cutini S, D’Ammando F, Desiante R, Drell PS, Eggenstein HB, Favuzzi C, Fehrmann H, Ferrara EC, Focke WB, Franckowiak A, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Harding AK, Hays E, Hewitt JW, Hill AB, Horan D, Hou X, Jogler T, Johnson AS, Jóhannesson G, Kramer M, Krauss F, Kuss M, Laffon H, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lovellette MN, Lubrano P, Machenschalk B, Manfreda A, Marelli M, Mayer M, Mazziotta MN, Michelson PF, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nuss E, Ohsugi T, Orienti M, Orlando E, Palma FD, Paneque D, Pesce-Rollins M, Piron F, Pivato G, Rainò S, Rando R, Razzano M, Reimer A, Parkinson PMS, Schaal M, Schulz A, Sgrò C, Siskind EJ, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Tibaldo L, Torne P, Torres DF, Tosti G, Troja E, Vianello G, Wood KS, Wood M, Yassine M. PSR J1906+0722: AN ELUSIVE GAMMA-RAY PULSAR. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/2041-8205/809/1/l2] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|